Survival outcomes of elderly patients undergoing transcatheter aortic valve implantation after 3 years of follow-up

Table 5 Multivariate regression model for early mortality risk after transcatheter aortic valve implantation

Variables	OR (95%CI)	P value
Male sex	6.38 (0.53-76.36)	0.144
BMI ≥ 30	3.13 (1.01-4.75)	0.042
Diabetes mellitus	0.42 (0.08-2.20)	0.301
Hypertension	0.71 (0.12-4.14)	0.701
Dyslipidemia	4.20 (0.67-26.42)	0.127
Dementia	0.16 (0.01-4.23)	0.274
Rheumatic heart disease	2.78 (1.01-4.57)	0.876
Cancer within 5 years	0.83 (0.01-1.21)	0.911
Smoking	2.59 (0.15-43.26)	0.509
ESRD	1.23 (0.02-6.79)	0.922
Previous cardiac intervention	0.98 (0.10-10.20)	0.988
Previous cardiac surgery	0.17 (0.01-4.10)	0.277
History of MI	1.16 (0.19-7.01)	0.873
Coronary artery disease	2.71 (0.31-23.30)	0.365
Numbers of vessels > 50%	1.00 (0.91-1.11)	0.942
Heart failure	0.27 (0.02-4.24)	0.348
NYHA classification > 4	1.05 (0.89-1.22)	0.573
Atrial fibrillation/flutter	1.11 (0.10-12.04)	0.932
Cerebrovascular disease	0.85 (0.06-12.87)	0.907
Sleep apnea	0.42 (0.12-0.92)	0.826
Liver disease	0.58 (0.20-0.91)	0.887
COPD	1.96 (0.04-91.33)	0.732
Oxygen dependence	3.55 (0.98-5.12)	0.465
Carotid artery disease	6.15 (2.43-9.31)	0.041
Pacemaker insertion	1.66 (0.15-2.43)	0.912
Pulmonary hypertension	9.14 (5.72-17.32)	0.021

BMI: Body mass index; CI: Confidence interval; COPD: Chronic obstructive pulmonary disease; ESRD: End-stage renal disease; MI: Myocardial infarction; NYHA: New York Heart Association; OR: Odds ratio.